It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2013.
2013 | Bangalore, Karnataka, India | ActiveMedzip Pharmaceuticals Private Limited, a active private limited company, was established on 28 November 2013 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: U24301KA2013PTC072177. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.15 M and a paid-up capital of ₹0.15 M.
It upholds a compliant status. Its leadership includes Kalpana Anilkumar Pacheri (Director), Anand Pandurang Kulkarni (Director), Purnapradna Ranjan Kulkarni (Director). Past directors included Kalpana Anilkumar Pacheri. It holds ₹0.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 12, 8Th F Cross,Vidyamanyanagara Andra Halli Main Road,, Bangalore, Karnataka, 560091.
U24301KA2013PTC072177
072177
28 November 2013
₹0.15 M
₹0.15 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Medzip Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kalpana Anilkumar Pacheri | Director | 21 Jan 2014 | Current |
| Anand Pandurang Kulkarni | Director | 28 Nov 2013 | Current |
| Purnapradna Ranjan Kulkarni | Director | 28 Nov 2013 | Current |
| Santosh Baburao Bommannavar | Director | 28 Nov 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medzip Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 12.79% decrease. The company also saw a substantial improvement in profitability, with a 15.84% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Medzip Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Mar 2016 | Others | ₹0.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medzip Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medzip Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medzip Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Medzip Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Medzip Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.50 M with Charge ID 100016660 was registered on 10 Mar 2016. was completed.
Progress on Kalpana Anilkumar Pacheri was appointed as a Director was appointed as a Director on 21 Jan 2014 & has been associated with this company since 11 years 10 months . was documented.
Progress on Anand Pandurang Kulkarni was appointed as a Director was appointed as a Director on 28 Nov 2013 & has been associated with this company since 12 years 4 days . was documented.
Progress on Purnapradna Ranjan Kulkarni was appointed as a Director was appointed as a Director on 28 Nov 2013 & has been associated with this company since 12 years 4 days . was documented.
The CIN of Medzip Pharmaceuticals Private Limited is U24301KA2013PTC072177.
Medzip Pharmaceuticals Private Limited is headquartered at 12, 8Th F Cross,Vidyamanyanagara Andra Halli Main Road,, Bangalore, Karnataka, 560091.
Medzip Pharmaceuticals Private Limited was incorporated on 28 November 2013.
The current directors of Medzip Pharmaceuticals Private Limited are
The primary industry of Medzip Pharmaceuticals Private Limited is Professional, Scientific And Technical.
Medzip Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medzip Pharmaceuticals Private Limited is ₹0.15 M, and the paid-up capital is ₹0.15 M.
The compliance status of Medzip Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX